Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Oncology, Volume 56, Number 09, September 2011, Joe Munch, Bryan Tutt
Oncology, Volume 56, Number 09, September 2011, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Novel Agents for Castrate-Resistant Prostate Cancer Include Potent Androgen Blockers and Immunotherapies: Despite progress in screening and therapy, prostate cancer continues to be a leading cause of cancer death among men worldwide
- New Targeted Therapy Offers Hope in Relapsed Hodgkin and Anaplastic large-Cell Lymphoma: The U.S. Food and Drug Administration (FDA) has approved the first new drug for Hodgkin Lymphoma since 1977
- HOUSE CALL: Colorectal Cancer Screening: Risk factors determine who should be screened and how often
- IN BRIEF: Everolimus may Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer Patients
Oncolog, Volume 56, Number 02, February 2011, Joe Munch, John Lebas
Oncolog, Volume 56, Number 02, February 2011, Joe Munch, John Lebas
OncoLog MD Anderson's Report to Physicians (All issues)
- Risk-Based Cancer Screening: M.D. Anderson's revised guidelines offer more precise individualized recommendations on screening for common cancers.
- Screen Guidelines in Brief
- Electronic Navigation Biopsy for Peripheral Lung Lesion Diagnosis
- House Call: Couples and Cancer: Cancer-Related Issues Can Disrupt Relationships
- in Brief: Researchers Find Glioblastoma's Resistance to Treatment Rooted in Immunosuppression